Technical Analysis for PFNX - Pfenex Inc.

Grade Last Price % Change Price Change
grade D 8.32 0.60% 0.05
PFNX closed up 0.6 percent on Thursday, July 2, 2020, on 74 percent of normal volume.

Trend Table & Recent Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Up Down
Historical PFNX trend table...

Date Alert Name Type % Chg
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 0.00%
Bollinger Band Squeeze Range Contraction 0.00%
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 0.60%
Bollinger Band Squeeze Range Contraction 0.60%
NR7 Range Contraction 0.60%
BB Squeeze Started Range Contraction 0.60%
Inside Day Range Contraction 0.60%
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup -0.36%
Outside Day Range Expansion -0.36%
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup -1.19%

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Pfenex Inc., a clinical-stage biotechnology company, is engaged in the development of biosimilar therapeutics. Its lead product candidate includes PF582, a biosimilar candidate to Lucentis that is in Phase Ib/IIa trials in patients with wet age-related macular degeneration. The company also develops PF530, an interferon beta-1b biosimilar candidate to the Betaseron to reduce the relapses in patients with relapsing forms of multiple sclerosis; PF694, an interferon alpha-2a biosimilar candidate to the reference product Pegasys; and other biosimilar candidates. In addition, it develops PF708, a teriparatide generic peptide product candidate to the reference listed drug Forteo; Px563L, an anthrax vaccine candidate based on a recombinant modified form of the protective antigen; and Px533, a prophylactic vaccine candidate to protect against malaria infection. The company has collaboration with Strides Arcolab Limited for the development of PF530. Pfenex Inc. is headquartered in San Diego, California.
Medicine Biotechnology Life Sciences Biology Drugs Multiple Sclerosis Wet Age Related Macular Degeneration Biosimilar Anthrax Antivirals Interferon

Is PFNX a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 14.0
52 Week Low 5.26
Average Volume 378,599
200-Day Moving Average 9.43
50-Day Moving Average 7.42
20-Day Moving Average 8.61
10-Day Moving Average 8.40
Average True Range 0.71
ADX 19.11
+DI 19.30
-DI 22.32
Chandelier Exit (Long, 3 ATRs ) 8.22
Chandelier Exit (Short, 3 ATRs ) 9.29
Upper Bollinger Band 9.50
Lower Bollinger Band 7.72
Percent B (%b) 0.34
BandWidth 20.63
MACD Line 0.18
MACD Signal Line 0.29
MACD Histogram -0.107
Fundamentals Value
Market Cap 195.74 Million
Num Shares 23.5 Million
EPS 0.06
Price-to-Earnings (P/E) Ratio 138.67
Price-to-Sales 1.08
Price-to-Book 1.09
PEG Ratio -0.03
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 9.24
Resistance 3 (R3) 9.18 8.83 9.08
Resistance 2 (R2) 8.83 8.59 8.85 9.03
Resistance 1 (R1) 8.57 8.45 8.40 8.63 8.98
Pivot Point 8.22 8.22 8.13 8.24 8.22
Support 1 (S1) 7.96 7.98 7.79 8.02 7.66
Support 2 (S2) 7.61 7.84 7.63 7.61
Support 3 (S3) 7.35 7.61 7.56
Support 4 (S4) 7.41